Clinical Trial Update: Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating lenvatinib for anaplastic thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Anaplastic Thyroid Cancer | Phase 2 | Status: COMPLETED